European Patent Office

T 2566/11 of 17.09.2015

European Case Law Identifier
ECLI:EP:BA:2015:T256611.20150917
Date of decision
17 September 2015
Case number
T 2566/11
Online on
18 January 2016
Petition for review of
-
Application number
02785879.4
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
EXTENDED RELEASE COMPOSITIONS COMPRISING AS ACTIVE COMPOUND VENLAFAXINE HYDROCHLORIDE
Applicant name
KRKA, tovarna zdravil, d.d., Novo mesto
Opponent name
Alfred E. Tiefenbacher GmbH & Co. KG
Hennig Arzneimittel GmbH & Co. KG
STRAWMAN LIMITED
Wyeth LLC
Board
3.3.07
Headnote
-
Relevant legal provisions
Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 12(1)European Patent Convention Art 56 1973Rules of procedure of the Boards of Appeal Art 12(4)
Keywords
Inventive step - main request and auxiliary requests 1 to 6 (no)
Auxiliary requests 1 to 6 - admitted (yes)
Late-filed auxiliary requests 7 - admitted (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.